Article Public (all visitors)

Regeneron Antibody Therapy For Covid-19 Enters Late-Stage Trials

Forbes 2020

The trial will assess if the drug may be able to prevent infection among patients who have been exposed and treat those who have been infected with the disease.

Curated by

FoundryBase

Updated 19 days ago

Browse more

View all Articles

Adjacent discoveries

Related resources

Continue from source

More from source

Browse more from Forbes

Contribute to FoundryBase

Found something worth adding?

Sign in to suggest resources and start building your own collection.